Israeli Technologies Impacting the Global Medical Sector

Israeli Technologies Impacting the Global Medical Sector

Gaining efficiency in commercial ventures in global medical devices industry by effectively collaborating with key innovation stakeholders in Israel

RELEASE DATE
30-Dec-2016
REGION
Europe
Research Code: D7A4-01-00-00-00
SKU: HC02701-EU-TR_19250

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC02701-EU-TR_19250

$4,950.00

$3,712.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

Over the past two decades, Israel had risen to be an global medical devices innovation hub, reinforcing its position as one of the major contributors to the growth of the innovations in the global medical devices sector. With a plethora of scientific resources, ease of conducting clinical research studies, globally competitive intellectual portfolio management practices, access to global investor networks, inclusion of a collaborative work culture and extensive knowledge in commercializing cutting-edge technologies, Israel is one of the countries that has found profound success in devising safe and effective therapies for addressing debilitating medical disorders. This research service evaluates the commercial impact and stakeholder strategies for top medical devices technologies in Israel, which include neuroprostheses, X-eluting stents, smart pills, surgical robotics, surgical lasers, and neuromodulation therapies.

The following questions are answered in this report:
1. Who are the various innovation stakeholders (such as technology developers, clinical researchers and investors) in Israel that enable its development as a global innovation hub for medical devices?
2. What is the intensity of commercialization efforts that are happening across major cities (regional innovation hubs) of Israel namely, Tel Aviv, Jerusalem, Haifa, Yokneam, Ra'anana, Herzliya, Beer'Sheva, and Cesaerea?
3. Identifying the competencies of regional innovation hubs in Israel to sustainable innovate cutting-edge medical device technologies.
4. What are the strategic gaps that exist in the existing innovation ecosystem in Israel, and how commercial opportunities available for innovators in both Israeli and global players span out near-to-far term investments in Israel medical devices sector?
5. What are the strategic recommendations of analysts to stakeholders when evaluating early investment opportunities in Israel's medical devices sector?
6. Gather additional knowledge and recommendations in evaluating commercial partnership initiatives such as cross-selling agreements, in-organic growth initiatives such as acquisition or merger of Israeli firms, and regional/international collaborations on clinical trials.
7. How is the patent landscape in Israel for top medical device technologies? Why global companies hold most regional patents, and Israeli-based firms holding patents in matured medical device markets (especially in the USA and Europe)?

Table of Contents

1.1 Objectives of Research

1.2 Research Methodology

2.1 High Adoption of Surgical Robotics and Neuromodulation Therapies by Healthcare Providers

2.2 Medinol is one of the Pioneers in the Israeli Stents

2.3 Demonstrating Outcomes of Clinical Trials Paves Way for Global Market Expansion

3.1 Intensity of Addressable Market Segments is High for Neuromodulation Therapies

3.2 Yokneam and Caesarea have risen to be Prominent Industrial Innovation Hubs

3.3 Access to Experienced Clinical Researchers is Key to Sustainable Innovation

3.4 Israel Houses World-class Academic and Clinical Research Institutions that Drive Wide Technology Developments

3.5 Surgical Lasers is one of the Matured Industry Sector in Israel

3.6 Collaborative Clinical Trials Yield Major Results for Medical Device Innovators in Israel

4.1 Israel Houses some of the Leading Developers of Neuroprosthetics Globally

4.2 Multicenter Studies will be Highly Beneficial in Mitigating Incidence of Highly Adverse Events

5.1 Israeli Stent Makers Continue to Focus on Developing New Products

5.2 Current Studies Evaluate the Design of Hybrid Stents Containing Metallic Elastomeric Mesh

5.3 Developers Focus on Disposable Mounted Cobalt-chromium (CoCr) Alloy-based Stent

6.1 Given Imaging (Medtronic) is one of the Country’s Leading Smart Pill Manufacturer

6.2 Drug-delivery Combination Devices is Emerging with Very High Commercial Prospects in the Market

7.1 Israel Attracts Major Investments in the Area of Robotic Surgical Systems

7.2 Robotic Surgery Enables Surgeons to Automate Performance of Complex Surgical Procedures

8.1 Surgical Laser Technologies are used Extensively across Major Hospitals in Israel

8.2 Surgical Lasers can also be used in the Miniaturization of Various Medical Device Components

9.1 Sheba Medical Center conducts Clinical Study on Various Indications using Neuromodulation Therapies

9.2 Technology Developers in Israel have been able to Demonstrate the Commercial Potential of Their Therapies

10.1 Acquisition of Given Imaging by Covidien is among the Major Deals in the Israeli Neuromodulation Industry

10.2 Funding Initiatives Focus on Pursuit of Clinical Trials, and Regulatory Approvals in Europe and US Markets

10.3 More Collaborative Research Initiatives Toward Pursuit of Touch-enabled Neuroprosthesis

10.4 Global Device OEMs Enter into Cross-selling Agreements with Israeli Technology Developers

10.5 SCP Vitalife Partners and TriVentures are Top Investors in Emerging Medical Device Technologies in Israel

10.6 Israeli Medical Device Design and Development Services is an Emerging Business Model

10.7 Israel is an Established Medical Device Hub, and Serves to Fuel the Global Medical Community

10.8 Israel Hosts Ideal Support Structure for Firms to Innovate for Demands of the Global Healthcare Community

11.1 High Variation in Conversion of Applied Patents to Granted Patents for Top Medical Device Innovations

11.2 Key Patents on Therapeutic Neuromodulation of the Hepatic System, and Thermally-induced Renal Neuromodulation

11.3 Key Patents on Systems and Methods for Facilitating Robotic Surgical Laser Procedures, and Systems Useful in Registration

11.4 Key Patents on Rapamycin Reservoir Eluting Stent & Devices for Advancement of Stents

12.1 List of Key Industry Participants

12.1 List of Key Industry Participants (continued)

Legal Disclaimer

13.1 The Frost & Sullivan Story

13.2 Value Proposition: Future of Your Company & Career

13.3 Global Perspective

13.4 Industry Convergence

13.5 360º Research Perspective

13.6 Implementation Excellence

13.7 Our Blue Ocean Strategy

Related Research
Over the past two decades, Israel had risen to be an global medical devices innovation hub, reinforcing its position as one of the major contributors to the growth of the innovations in the global medical devices sector. With a plethora of scientific resources, ease of conducting clinical research studies, globally competitive intellectual portfolio management practices, access to global investor networks, inclusion of a collaborative work culture and extensive knowledge in commercializing cutting-edge technologies, Israel is one of the countries that has found profound success in devising safe and effective therapies for addressing debilitating medical disorders. This research service evaluates the commercial impact and stakeholder strategies for top medical devices technologies in Israel, which include neuroprostheses, X-eluting stents, smart pills, surgical robotics, surgical lasers, and neuromodulation therapies. The following questions are answered in this report: 1. Who are the various innovation stakeholders (such as technology developers, clinical researchers and investors) in Israel that enable its development as a global innovation hub for medical devices? 2. What is the intensity of commercialization efforts that are happening across major cities (regional innovation hubs) of Israel namely, Tel Aviv, Jerusalem, Haifa, Yokneam, Ra'anana, Herzliya, Beer'Sheva, and Cesaerea? 3. Identifying the competencies of regional innovation hubs in Israel to sustainable innovate cutting-edge medical device technologies. 4. What are the strategic gaps that exist in the existing innovation ecosystem in Israel, and how commercial opportunities available for innovators in both Israeli and global players span out near-to-far term investments in Israel medical devices sector? 5. What are the strategic recommendations of analysts to stakeholders when evaluating early investment opportunities in Israel's medical devices sector? 6. Gather additional knowledge and recommendatio
More Information
No Index No
Podcast No
Author Arjunvasan Ambigapathy
Industries Healthcare
WIP Number D7A4-01-00-00-00
Is Prebook No